KRAS and adenocarcinoma: This conclusion appears consistent with the somewhat mixed inclusion of EGFR-mutated, KRAS-mutated and EGFRwt/KRASwt adenocarcinomas in different reported molecular subtypes of adenocarcinomas [16,19,20].